Moffitt logo

Articles related to Immunotherapy

Pam-Griffith-LATTE.jpg

Immunotherapy Clinical Trial Brought Renewed Hope To Lung Cancer Patient

My husband and I celebrated our 50th wedding anniversary last year and know without a doubt that I would not be alive today if we had not sought treatment at Moffitt Cancer Center. Read More


Immontherapy-Pipette-Cells-Cropped.jpg

Is Immunotherapy the Key to Fighting Ovarian Cancer?

Oncologists believe immunotherapy could be the missing piece of the puzzle. Read More


SU2C.jpg

Moffitt Uses Innovative Immunotherapy to Stand Up To (Lung) Cancer

The unique clinical trial combining two immunotherapies is funding by the Stand Up To Cancer Catalyst® Program. Read More



Bonnethead-Shark.jpg

Healing Power of Sharks May Hold Cancer Clues

Research on the unique immune system of the shark may aid in the fight against cancer Read More


CAR T Leukemia Cell.jpg

CAR T Drives New Ovarian Cancer Research

Moffitt could launch CAR T-cell therapy clinical trials as soon as next year. Read More


IMG_32161.jpg

CAR T Provides Remission, Purpose for Moffitt Leukemia Patient

Case Marks First Time CAR T Induces AML Remission Read More


marjorie-family.jpg

Immunotherapy Key to Unlocking Lung Cancer Survival

A recent study represents another step forward in immunotherapy, which has been making steady gains in recent years. Read More


lung-cancer-research-640.jpg

Moffitt’s Top Research Developments of 2017: Novel Combination Approach to Lung Cancer Wins Moffitt a Stand Up To Cancer Grant

The second one on the list of Moffitt research developments involves a grant to study how immunotherapy can change the way the cancer center is treating lung cancer. Read More


Locke-research-lab.jpg

Moffitt’s Top Research Developments of 2017: CAR T Therapy Tested, Commercially Available at Moffitt

The first one on the list of Moffitt's top research developments for 2017 is the FDA approval of CAR T therapy for certain aggressive types of adult lymphoma. Read More


CART-Cell-Illustration-640.jpg

Moffitt Treats First U.S. Patient with Newly FDA-Approved CAR T Therapy

Moffitt has treated the first U.S. adult lymphoma patient with a therapy formerly available only through clinical trials. Read More


CART-teaser.jpeg

Infographic: How CAR T Therapy Works to Fight Cancer

CAR T therapy, a groundbreaking new treatment, utilizes the body’s own immune system to fight cancer. Read More


CART-lab-640.jpg

What is CAR T Therapy?

Dr. Frederick Locke, vice chair of the Department of Blood and Marrow Transplant and Cellular Immunotherapy, answers some frequently asked questions about CAR T cell therapy. Read More


DrFredLocke-CART-640.jpg

CAR T Cancer Therapy a ‘Huge Breakthrough’ for Patients with Lymphoma

Moffitt patients with an aggressive type of lymphoma were among the first to benefit in clinical trials of a groundbreaking therapy. Read More


Locke-blog.jpg

Dr. Locke: CAR-T Cell Therapy a 'Revolution in Cancer Care'

Dr. Locke, the principal investigator for a new experimental immunotherapy called CAR T-cell therapy, talks about the breakthroughs with this type of treatment. Read More


COMMUNITY OF COURAGE

STORIES TO INSPIRE YOU ON YOUR JOURNEY THROUGH CANCER